Somatostatin and neuropeptide Y immunoreactivity in parkinson's disease dementia with alzheimer's changes

Synapse

Volumn 2, Issue 4, 1988, Pages 463-467

  Flint Beal, M ^a   Clevens, Ross A ^a   Mazurek, Michael F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Alzheimer's disease; Neuropeptide Y; Parkinson's disease

Indexed keywords

NEUROPEPTIDE Y; SOMATOSTATIN;

AUTOPSY; BRAIN CORTEX; CLINICAL ARTICLE; DEMENTIA; HISTOCHEMISTRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PARKINSON DISEASE;

AGED; ALZHEIMER DISEASE; FEMALE; HUMAN; MALE; MIDDLE AGE; NEUROPEPTIDE Y; PARKINSON DISEASE; SOMATOSTATIN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023706617     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.890020415     Document Type: Article

References (44)

1. Biochemistry of neurotransmitters in Parkinson's disease
2. Dissociation of neuropeptide Y and somatostatin in Parkinson's disease
3. Elevation of neuropeptide Y (NPY) in substantia innominata in Alzheimer's type dementia
4. The morphological basis of dementia in Parkinson's disease
5. Somatostatin 28 (1–12)‐like immunoreactivity is reduced in Alzheimer's disease in cerebral cortex
6. CSF somatostatin‐like immunoreactivity in dementia
7. Neuropeptides in Alzheimer's disease
8. Topographical dopamine and serotonin distribution and turnover in rat striatum
9. Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease
10. An examination of neuropeptide Y postmortem stability utilizing a new radioimmunoassay
11. Somatostatin immunoreactivity is reduced in Parkinson's disease dementia with Alzheimer's changes
12. Widespread reduction of somatostatin‐like immunoreactivity in the cerebral cortex in Alzheimer's disease
13. Fluorometric assay of proteins in the nanogram range
14. Parkinson's disease, dementia and Alzheimer's disease: Clinicopathologic correlations
15. How common is dementia in Parkinson's disease?
16. Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's disease
17. Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold/silver intensification on vibratome sections; coexistence with neuropeptide Y neurons, and effects in Alzheimer‐type dementia
18. Cortical neurons immunoreactive with antisera against neuropeptide Y are altered in Alzheimer's‐type dementia
19. Distribution of altered hippocampal neurons and axons immunoreactive with antisera against neuropeptide Y in Alzheimer's‐type dementia
20. Coexistence of neuropeptide Y and somatostatin in rat and human cortical and rat hypothalamic neurons
21. Pathologic correlates of dementia in Parkinson's disease
22. Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type
23. Neuropathologic and clinical features of Parkinson's disease in Alzheimer's patients
24. Demence et maladie de Parkinson: Correlations biochemiques et anatocliniques
25. A subcortico‐cortical cholinergic system is affected in Parkinson's disease
26. Somatostatin and dementia in Parkinson's disease
27. Brain choline acetyltransferase activity and neuropeptide Y concentrations in Alzheimer's disease
28. Somatostatin and neuropeptide Y innervation in the septal area and related cortical and subcortical structures of the human brain. Distribution, relationships and evidence for differential coexistence
29. Dementia in idiopathic Parkinson's disease: A neuropathological study of 32 cases
30. Dementia in Parkinson's disease: a neuropathologic study
31. Morphology, distribution and synaptic relations of somatostatin and neuropeptide Yimmunoreactive neurons in rat and monkey neocortex
32. Dementia in Parkinson's disease
33. Alzheimer's disease: Glutamate depletion in the hippocampal perforant pathway zone
34. Cortical vasoactive intestinal peptide in relation to dementia in Parkinson's disease
35. Dementia in Parkinson's disease and (pre) senile dementia of Alzheimer's type: Morphological aspects and changes in the intracerebral MAO activity
36. Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: Normal anatomy and alterations in Alzheimer's disease
37. Parkinson's disease in patients with Alzheimer's disease
38. Dementia in Parkinson's disease
39. A controlled study of dementia in Parkinson's disease
40. Somatostatin and neuropeptide Y‐immunoreactive neurons in the neocortex in senile dementia of Alzheimer's type
41. Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease
42. Cholinergic correlates of cognitive impairment in Parkinson's disease: Comparisons with Alzheimer's disease
43. Location of neuronal tangles in somatostatin neurons in Alzheimer's disease
44. Neuropeptide coexistence in human cortical neurons